These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26261605)

  • 1. Expression of Wnt11 and Rock2 protein with clinical characteristics of esophageal squamous cell carcinoma in Kazakh and Han patients.
    Liu D; Zhou K; Li Q; Deng F; Ma Y
    Int J Clin Exp Pathol; 2015; 8(6):7122-30. PubMed ID: 26261605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Wnt11 and Rock2 in esophageal squamous cell carcinoma by activation of the WNT/PCP pathway and its clinical significance.
    Wang X; Liu D; Zhou K; Wang B; Liu Q; Deng F; Li Q; Ma Y
    Pathol Res Pract; 2016 Oct; 212(10):880-885. PubMed ID: 27628667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.
    Cui X; Li S; Li T; Pang X; Zhang S; Jin J; Hu J; Liu C; Yang L; Peng H; Jiang J; Liang W; Suo J; Li F; Chen Y
    Int J Clin Exp Pathol; 2014; 7(5):2382-91. PubMed ID: 24966948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
    Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
    Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
    Hasan R; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
    BMC Cancer; 2014 Jan; 14():2. PubMed ID: 24383423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
    Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
    Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
    APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.
    Zhang Y; Zhang YL; Chen HM; Pu HW; Ma WJ; Li XM; Ma H; Chen X
    World J Gastroenterol; 2014 May; 20(18):5533-9. PubMed ID: 24833884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
    Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
    Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
    Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between ROCK2 expression and clinicopathologic characteristics of esophageal squamous cell carcinoma].
    Yibulayin W; Chen ZL; Tan FW; Sun N; He J
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2038-41. PubMed ID: 22093931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma.
    Hiyoshi Y; Watanabe M; Hirashima K; Karashima R; Sato N; Imamura Y; Nagai Y; Yoshida N; Toyama E; Hayashi N; Baba H
    Oncol Rep; 2009 Jul; 22(1):35-9. PubMed ID: 19513502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients.
    Ma MQ; Yu ZT; Tang P; Jiang HJ; Zhao XJ; Zhang JG; Qu DW; Jin QW; Zhang XZ
    Int J Clin Exp Pathol; 2015; 8(5):5008-16. PubMed ID: 26191194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.
    Dourado MR; de Oliveira CE; Sawazaki-Calone I; Sundquist E; Coletta RD; Salo T
    J Oral Pathol Med; 2018 Feb; 47(2):121-127. PubMed ID: 29052912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.
    Kitaichi T; Yasui K; Gen Y; Dohi O; Iwai N; Tomie A; Yamada N; Terasaki K; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Naito Y; Zen Y; Itoh Y
    Hum Pathol; 2017 Apr; 62():134-140. PubMed ID: 28188749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.